Medix (331A) · InitiativeFirst stated

Enhancing the Objectivity of Director Nominations and Compensation through the Nomination and Compensation Committee

First written in FY2026. . Latest entry: FY2026.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Operation of the Nomination and Compensation Committee Centered on Independent Outside DirectorsA theme 250 companies write about · 0 as a headwind · 250 as a tailwind

The whole theme swung hardest in 2025: 8 of 86 companies on the "Worse" side.

11 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 250 threads.

Full recordFilings, disclosures and news, newest first

FY2026First statedAnnual report
「We have established a voluntary Nominating and Compensation Committee as an advisory body to the Board of Directors in order to strengthen the independence, objectivity and accountability of the Board's functions relating to the nomination of directors and the compensation of directors other than those serving as Audit and Supervisory Committee members. As a rule, the Nominating and Compensation Committee meets 3 times a year, as well as whenever necessary.」
The Company established a voluntary Nominating and Compensation Committee with a majority of outside directors, creating a structure to enhance the independence, objectivity and accountability of director nominations and compensation.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

Medix's next results are scheduled for 2026-11-10. Read the earnings preview

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.